Pfizer Inc. said Tuesday it is cooperating with a federal investigation into whether it's improperly marketing Lipitor, a cholesterol-lowering drug that is the world's top-selling medicine. Teamsters Local 863 charges that the New York-based company has cost drug plans billions of dollars in unwarranted prescriptions since 2001. The labor union's lawsuit, filed Monday in U.S. District Court in Newark, N.J., seeks class action status for drug plans that have covered Lipitor prescriptions.
March 29, 2006 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Pfizer Inc. on Tuesday said it is cooperating with a federal investigation into whether it is improperly marketing Lipitor, a cholesterol-lowering drug that is the world’s top-selling medicine.
“We do not know who initiated or why an investigation was initiated in Brooklyn, but we have been cooperating with that investigation and have seen no merit in any of the claims in that matter,” a spokesman for Pfizer, Andrew B. McCormick, said in an e-mail Tuesday.
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Women, Influence & Power in Law Awards honors women lawyers who have made a remarkable difference in the legal profession.
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Javerbaum Wurgaft, a large civil litigation firm with nine (9) offices, seeks: Plaintiff Personal Injury Attorney for Northern New Jersey of...
Exciting Career Opportunities at Nuzzo & Roberts! Nuzzo & Roberts, a leading mid-sized insurance defense firm based in Cheshire, CT...
